National Science and Technology Development Agency, Thailand Report issue

Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2009
NCT00826163
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

budesonide (rhinocort) (1 trial)

epidermal growth factor (1 trial)

silver sulfadiazine (silvadene) (1 trial)

Drugs in Phase 2 Trials (1)

calcitriol (rocaltrol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Burns (Phase 3)

Cholangiocarcinoma (Phase 2)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4